Dr. Costin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Longview Ave
Ste. 201
White Plains, NY 10601Phone+1 914-684-2779Fax+1 914-684-6859
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 1991 - 1993
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1990 - 1991
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1987 - 1990
University of California San Francisco School of MedicineClass of 1987
Certifications & Licensure
NY State Medical License 1991 - 2026
MD State Medical License 1990 - 1992- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 2005
- Top MD Consumers Checkbook
Clinical Trials
- A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment Start of enrollment: 2012 Jan 01
- Pancreatic Cancer Early Detection Program Start of enrollment: 2014 Apr 01
- Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer Start of enrollment: 2017 Jan 18
Publications & Presentations
PubMed
- 103 citationsReceptor Tyrosine Kinase Fusions and BRAF Kinase Fusions are Rare but Actionable Resistance Mechanisms to EGFR Tyrosine Kinase Inhibitors.Alexa B. Schrock, Viola W. Zhu, Wen-Son Hsieh, Russell Madison, Benjamin Creelan
Journal of Thoracic Oncology. 2018-09-01 - 2 citationsPrimary pulmonary carcinoid tumor with metastasis to endometrial polypMazdak Momeni, Valentin Kolev, Dan Costin, Howard H. Mizrachi, Linus Chuang
International Journal of Surgery Case Reports. 2013-01-01 - 59 citationsChemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogsRobert Silber, Barbara A. Degar, Dan Costin, Elizabeth W. Newcomb, Mathew Mani
Blood. 1994-11-15
Press Mentions
The Next Generation of Cancer Vaccines Are Coming; What That Means for Moderna and Other Biotech StocksFebruary 24th, 2023
Fighting Cancer: One Patient's StoryMay 11th, 2016
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
